Policy & Regulation
18 January 2018 - - The Woodbury, New York-based pancreatic research funding organization Lustgarten Foundation funded USD 22m in 2017 as part of its commitment to invest USD 40m by the end of 2018, t...
18 January 2018 - - St. John's, Newfoundland and Labrador-based biotechnology company Sequence Bio has named Dr. Michael S. Phillips as chief scientific officer, the company said.
Phillips...
18 January 2018 - - The US Food and Drug Administration has accepted the biologics license application from Holzkirchen, Germany-based biosimilar medicines specialist Sandoz, a Novartis division, subm...
18 January 2018 - GC Pharma, a South Korean biopharmaceutical company, announced yesterday that it will proceed with a Phase 2/3 clinical trial for GC1102 (also known as Hepabig-gene).The company'...
18 January 2018 - United States-based Merck's Keytruda (pembrolizumab) in combination with pemetrexed (Alimta) plus platinum chemotherapy has improved overall survival and progression-free surviv...
18 January 2018 - Ireland-based Shire has received marketing authorisation from the European Commission for its Adynovi [Antihaemophilic Factor (Recombinant), PEGylated], an extended half-life recombi...